Publicaciones en las que colabora con EMILIO AMBROSIO FLORES (19)

2024

  1. Lack of interactions between prenatal immune activation and Δ9-tetrahydrocannabinol exposure during adolescence in behaviours relevant to symptom dimensions of schizophrenia in rats

    Progress in neuro-psychopharmacology & biological psychiatry, Vol. 129, pp. 110889

2023

  1. Interaction between maternal immune activation and peripubertal stress in rats: impact on cocaine addiction-like behaviour, morphofunctional brain parameters and striatal transcriptome

    Translational Psychiatry, Vol. 13, Núm. 1

2022

  1. Effects of heroin self-administration and forced withdrawal on the expression of genes related to the mTOR network in the basolateral complex of the amygdala of male Lewis rats

    Psychopharmacology, Vol. 239, Núm. 8, pp. 2559-2571

  2. Ex vivo 1H-MRS brain metabolic profiling in a two-hit model of neurodevelopmental disorders: Prenatal immune activation and peripubertal stress

    Schizophrenia Research, Vol. 243, pp. 232-240

  3. Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists

    Neuropharmacology, Vol. 221

2021

  1. Cocaine-induced Fos expression in the rat brain: Modulation by prior Δ9-tetrahydrocannabinol exposure during adolescence and sex-specific effects

    Brain Research, Vol. 1764

  2. Δ 9-Tetrahydrocannabinol during adolescence reprograms the nucleus accumbens transcriptome, affecting reward processing, impulsivity, and specific aspects of cocaine addiction-like behavior in a sex-dependent manner

    International Journal of Neuropsychopharmacology, Vol. 24, Núm. 11, pp. 920-933

2020

  1. Central nucleus of the amygdala as a common substrate of the incubation of drug and natural reinforcer seeking

    Addiction Biology, Vol. 25, Núm. 2

  2. Comparative analysis of the modulation of perineuronal nets in the prefrontal cortex of rats during protracted withdrawal from cocaine, heroin and sucrose self-administration

    Neuropharmacology, Vol. 180

  3. Maternal immune activation is associated with a lower number of dopamine receptor 3-expressing granulocytes with no alterations in cocaine reward, resistance to extinction or cue-induced reinstatement

    Pharmacology Biochemistry and Behavior, Vol. 193

  4. The effects of combined intravenous cocaine and ethanol self-administration on the behavioral and amino acid profile of young adult rats

    PLoS ONE, Vol. 15, Núm. 3

  5. The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1176-1199

2019

  1. Impulsive action and impulsive choice are differentially associated with gene expression variations of the GABAA receptor alfa 1 subunit and the CB1 receptor in the lateral and medial orbitofrontal cortices

    Frontiers in Behavioral Neuroscience, Vol. 13

  2. Morphine self-administration alters the expression of translational machinery genes in the amygdala of male Lewis rats

    Journal of Psychopharmacology, Vol. 33, Núm. 7, pp. 882-893

2017

  1. Strain differences in cannabinoid-reinforced lever press discrimination

    Journal of Drug and Alcohol Research, Vol. 6

2016

  1. Changes in D1 but not D2 dopamine or mu-opioid receptor expression in limbic and motor structures after lateral hypothalamus electrical self-stimulation: A quantitative autoradiographic study

    Neurobiology of Learning and Memory, Vol. 127, pp. 17-26

  2. Unaltered cocaine self-administration in the prenatal LPS rat model of schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 69, pp. 38-48

2015

  1. Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes

    Neuroscience and Biobehavioral Reviews, Vol. 55, pp. 119-146

2014

  1. Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 53, pp. 15-22